Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
- 1 January 2004
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 64 (22) , 2537-2565
- https://doi.org/10.2165/00003495-200464220-00004
Abstract
Type 2 diabetes mellitus is becoming a major health problem associated with excess morbidity and mortality. As the prevalence of type 2 diabetes is rapidly increasing, prevention of the disease...Keywords
This publication has 196 references indexed in Scilit:
- VALUE: analysis of resultsThe Lancet, 2004
- Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart diseaseAtherosclerosis, 2001
- Insulin Sensitivity in Patients with Essential Hypertension: No Influence of the ACE Inhibitor EnalaprilHormone and Metabolic Research, 1999
- A comparison of the hypotensive and hypoglycaemic actions of an angiotensin converting enzyme inhibitor, an AT1a antagonist and troglitazoneJournal Of Hypertension, 1996
- Relations Between Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Insulin Resistance, Glucose Intolerance, Hyperinsulinemia, and DyslipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The Link Between Insulin Resistance and HypertensionDrugs, 1994
- Angiotensin-Converting Enzyme (ACE) Inhibition Therapeutic Option for Diabetic Hypertensive PatientsDrugs, 1990
- A Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with HypertensionNew England Journal of Medicine, 1989
- Improved Insulin Response and Action by Chronic Magnesium Administration in Aged NIDDM SubjectsDiabetes Care, 1989
- Insulin Resistance in Essential HypertensionNew England Journal of Medicine, 1987